• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

    218.20 +2.51 (+1.16%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 572,014
    Open 218.93
    Bid (Size) 216.00 (100)
    Ask (Size) 222.00 (100)
    Prev. Close 215.69
    Today's Range 216.72 - 222.46
    52wk Range 109.40 - 260.19
    Shares Outstanding 47,190,970
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years ↗
    Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 46.84% on an annualized basis producing an average annual return of 58.59%. Currently, Axsome Therapeutics has a... 
    Via Benzinga
    News headline image
    If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today ↗
    Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 10 years by 26.64% on an annualized basis producing an average annual return of 40.19%. Currently, Axsome Therapeutics has a... 
    Via Benzinga

    Performance

    YTD
    +22.1%
    +22.1%
    1 Month
    -1.6%
    -1.6%
    3 Month
    -3.7%
    -3.7%
    6 Month
    +19.0%
    +19.0%
    1 Year
    +96.3%
    +96.3%

    More News

    Read More
    News headline image
    Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results ↗
    Via Benzinga
    News headline image
    Axsome Therapeutics Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prediction: These 2 Stocks Will Keep Winning No Matter What the Market Does ↗
    Via The Motley Fool
    News headline image
    Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Under-the-Radar Stocks to Buy and Hold ↗
    Via The Motley Fool
    News headline image
    Better Growth Buy: Axsome vs Revolution Medicines ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Is Axsome Therapeutics Stock a Millionaire Maker? Here's What the Numbers Say. ↗
    Via The Motley Fool
    News headline image
    Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
    Via The Motley Fool
    News headline image
    Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline ↗
    Via MarketBeat
    News headline image
    Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics to Participate in Upcoming Investor Conferences
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch ↗
    Via MarketBeat

    Frequently Asked Questions

    Is Axsome Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Axsome Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Axsome Therapeutics, Inc. - Common Stock trade on?
    Axsome Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Axsome Therapeutics, Inc. - Common Stock?
    The ticker symbol for Axsome Therapeutics, Inc. - Common Stock is AXSM on the Nasdaq Stock Market
    What is the current price of Axsome Therapeutics, Inc. - Common Stock?
    The current price of Axsome Therapeutics, Inc. - Common Stock is 218.20
    When was Axsome Therapeutics, Inc. - Common Stock last traded?
    The last trade of Axsome Therapeutics, Inc. - Common Stock was at 08/19/26 04:00 PM ET
    What is the market capitalization of Axsome Therapeutics, Inc. - Common Stock?
    The market capitalization of Axsome Therapeutics, Inc. - Common Stock is 10.30B
    How many shares of Axsome Therapeutics, Inc. - Common Stock are outstanding?
    Axsome Therapeutics, Inc. - Common Stock has 10B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.